Invivyd (IVVD) Gross Profit (QoQ) (2024 - 2025)

Invivyd (IVVD) Gross Profit (QoQ) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,200.25 Bn 66,199.96 Bn -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.75 Bn 466.96 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.94 Bn 114.69 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn
7 Belite Bio 62.43 Bn 62.43 Bn -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 Invivyd 105.26 Mn -121.43 Mn 16.07 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 33.44%
Sep 30, 2025 8.47%
Jun 30, 2025 6.03%
Mar 31, 2025 -20.05%
Dec 31, 2024 54.18%
Sep 30, 2024 290.35%